Previous 10 | Next 10 |
2024-03-26 11:45:41 ET More on Consumer Discretionary Select Sector SPDR ETF, SPDR S&P Retail ETF, etc. Read the full article on Seeking Alpha For further details see: Cons Disc distribution & retail has the highest dispersion among S&P groups - MS
2024-03-22 11:15:00 ET Summary A positive January for U.S. stocks is typically a prelude to a positive year, with our analysis finding the correlation to hold 80% of the time since 1928. Stocks look well-positioned to outperform bonds and cash again this year, but high valuations ...
2024-03-21 15:21:09 ET Summary In the last week(s) we have put on tactical hedges/shorts across our portfolio. While the indices look a little vulnerable here, there are many high-quality companies and turnaround stories that are just beginning their turnaround. One thing I am...
2024-03-20 11:40:18 ET Summary BlackRock Health Sciences Term Trust has seen its discount narrow somewhat since our last update, but it remains attractive still. BMEZ utilizes a covered call writing strategy and also provides some private investments to help deliver performance. ...
2024-03-20 04:50:32 ET Summary Shares of biotechnology companies have been lagging behind the S&P 500 Index. This underperformance of XBI relative to the S&P 500, however, has only made the opportunity even more attractive to us. Evidence of improving fundamentals and ...
2024-03-19 10:16:19 ET Summary Biotech M&A activity surged at the end of 2023, which helped the small biotech sector surge by 50% off its late October lows. Deal volume should remain strong in 2024 as large pharma concerns have large cash balances, face key patent expirations ...
2024-03-19 02:50:00 ET Summary Typically, a back-up in rates has led to a sell-off in stocks. We believe the current environment is different for three reasons: the degree of the move in rates, current economic cycle, and strength of mega-cap technology. In this environment, we wo...
2024-03-15 09:26:51 ET More on Genmab Genmab: Recent Updates Support The Growth Narrative Genmab A/S (GMAB) Q4 2023 Earnings Call Transcript Genmab's Arbitration Loss: Best To Forgive And Forget (Rating Upgrade) AbbVie/ Genmab win FDA priority review for lymp...
2024-03-14 14:54:38 ET More on Impel NeuroPharma, Infinity Pharmaceuticals, etc. Sorrento wins DoJ’s venue-based challenge to bankruptcy filing Scilex and Sorrento settle with Virpax and its founder Anthony Mack Financial information for Impel NeuroPharma ...
2024-03-13 13:29:04 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...
News, Short Squeeze, Breakout and More Instantly...
SPDR Series Trust S&P Biotech Company Name:
XBI Stock Symbol:
NYSE Market:
2024-07-08 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 13:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...